Correlation Between Genexine and MEDIPOST

Can any of the company-specific risk be diversified away by investing in both Genexine and MEDIPOST at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genexine and MEDIPOST into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genexine and MEDIPOST Co, you can compare the effects of market volatilities on Genexine and MEDIPOST and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genexine with a short position of MEDIPOST. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genexine and MEDIPOST.

Diversification Opportunities for Genexine and MEDIPOST

-0.71

Correlation Coefficient

Genexine  MEDIPOST

Pay attention - limited upside

The 3 months correlation between Genexine and MEDIPOST is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Genexine and MEDIPOST Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MEDIPOST and Genexine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genexine are associated (or correlated) with MEDIPOST. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MEDIPOST has no effect on the direction of Genexine i.e., Genexine and MEDIPOST go up and down completely randomly.

Pair Corralation between Genexine and MEDIPOST

Assuming the 90 days trading horizon Genexine is expected to generate 0.37 times more return on investment than MEDIPOST. However, Genexine is 2.7 times less risky than MEDIPOST. It trades about -0.18 of its potential returns per unit of risk. MEDIPOST Co is currently generating about -0.09 per unit of risk. If you would invest  551,000  in Genexine on October 24, 2024 and sell it today you would lose (43,000) from holding Genexine or give up 7.8% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Genexine  vs.  MEDIPOST Co

Genexine

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Genexine has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

MEDIPOST

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in MEDIPOST Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, MEDIPOST sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Genexine and MEDIPOST

The main advantage of trading using opposite Genexine and MEDIPOST positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genexine position performs unexpectedly, MEDIPOST can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEDIPOST will offset losses from the drop in MEDIPOST's long position.

The idea behind Genexine and MEDIPOST Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.